AR036096A1 - Formulacion farmaceutica de sabor enmascarado, un procedimiento para su preparacion y un procedimiento de enmascaramiento del sabor de productos farmaceuticos - Google Patents

Formulacion farmaceutica de sabor enmascarado, un procedimiento para su preparacion y un procedimiento de enmascaramiento del sabor de productos farmaceuticos

Info

Publication number
AR036096A1
AR036096A1 ARP020102300A ARP020102300A AR036096A1 AR 036096 A1 AR036096 A1 AR 036096A1 AR P020102300 A ARP020102300 A AR P020102300A AR P020102300 A ARP020102300 A AR P020102300A AR 036096 A1 AR036096 A1 AR 036096A1
Authority
AR
Argentina
Prior art keywords
procedure
flavor
preparation
pharmaceutical
masked
Prior art date
Application number
ARP020102300A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR036096A1 publication Critical patent/AR036096A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulación farmacéutica de sabor enmascarado, cuyo enmascaramiento persiste tras la administración de la formulación, especialmente en forma de suspensión en un vehículo acuoso, que comprende al menos los siguientes elementos: a) un polímero celulósico soluble en disolventes orgánicos, pero prácticamente insoluble en agua, independientemente de su pH; un polímero metacrílico soluble en medio ácido y prácticamente insoluble a pH neutro o alcalino; y un principio activo distribuido de manera homogénea y en estado molecular en la mezcla, la cual se presenta en forma de una matriz atomizada; b) un agente alcalino, de naturaleza orgánica, o una sal alcalina, farmacéuticamente aceptable; y c) un agente adsorbente; y al procedimiento para su preparación, así como a un procedimiento de enmascaramiento del sabor de productos farmacéuticos.
ARP020102300A 2001-06-21 2002-06-19 Formulacion farmaceutica de sabor enmascarado, un procedimiento para su preparacion y un procedimiento de enmascaramiento del sabor de productos farmaceuticos AR036096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (1)

Publication Number Publication Date
AR036096A1 true AR036096A1 (es) 2004-08-11

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102300A AR036096A1 (es) 2001-06-21 2002-06-19 Formulacion farmaceutica de sabor enmascarado, un procedimiento para su preparacion y un procedimiento de enmascaramiento del sabor de productos farmaceuticos

Country Status (42)

Country Link
US (2) US7138138B2 (es)
EP (1) EP1401397B1 (es)
JP (1) JP4880871B2 (es)
CN (1) CN1239149C (es)
AP (1) AP1595A (es)
AR (1) AR036096A1 (es)
AT (1) ATE290366T1 (es)
AU (1) AU2002329311B2 (es)
BG (1) BG66314B1 (es)
BR (1) BRPI0208998A2 (es)
CA (1) CA2452239C (es)
CO (1) CO5540278A2 (es)
CZ (1) CZ299947B6 (es)
DE (1) DE60203178T2 (es)
EA (1) EA006016B1 (es)
EC (1) ECSP034915A (es)
ES (1) ES2236574T3 (es)
FR (1) FR2826274B1 (es)
GT (2) GT200200115A (es)
HK (1) HK1067558A1 (es)
HR (1) HRP20031067B1 (es)
HU (1) HUP0400799A3 (es)
IL (2) IL159404A0 (es)
JO (1) JO2325B1 (es)
MA (1) MA27042A1 (es)
MX (1) MXPA03011756A (es)
MY (1) MY134340A (es)
NO (1) NO332258B1 (es)
NZ (1) NZ530042A (es)
OA (1) OA12635A (es)
PA (1) PA8548301A1 (es)
PE (1) PE20030201A1 (es)
PL (1) PL202090B1 (es)
PT (1) PT1401397E (es)
SK (1) SK285865B6 (es)
SV (1) SV2003001098A (es)
TN (1) TNSN03141A1 (es)
TW (1) TWI228049B (es)
UA (1) UA77960C2 (es)
UY (1) UY27341A1 (es)
WO (1) WO2003000225A2 (es)
ZA (1) ZA200309479B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
SI1978936T1 (sl) * 2006-02-03 2013-10-30 Evonik Roehm Gmbh Farmacevtski sestavki, ki vsebujejo mešanice polimerov in v vodi slabo topna aktivna sredstva
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
US20080181932A1 (en) * 2007-01-30 2008-07-31 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
BRPI0922385B1 (pt) 2008-12-16 2019-06-18 Carlsberg A/S Método para revestimento de superfícies hidroxiladas por enxerto em fase gasosa, material com superfície revestida e item
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
EP3185864A4 (en) * 2014-08-05 2018-03-28 Cempra Pharmaceuticals, Inc. Powder oral suspension formulations of antibacterial agents
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US6153220A (en) * 1997-10-03 2000-11-28 Elan Corporation, Plc Taste-masked formulations
IN191239B (es) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
ES2313975T3 (es) * 2000-08-22 2009-03-16 Basilea Pharmaceutica Ag Nuevos macrolidos con actividad antibacteriana.

Also Published As

Publication number Publication date
AP2003002927A0 (en) 2003-12-31
EP1401397B1 (fr) 2005-03-09
PA8548301A1 (es) 2003-09-05
GT200200115AA (es) 2005-01-12
ES2236574T3 (es) 2005-07-16
EA200400061A1 (ru) 2004-06-24
TNSN03141A1 (fr) 2005-12-23
DE60203178D1 (de) 2005-04-14
WO2003000225A2 (fr) 2003-01-03
GT200200115A (es) 2003-02-27
DE60203178T2 (de) 2006-01-26
PL366803A1 (en) 2005-02-07
CN1239149C (zh) 2006-02-01
HUP0400799A2 (hu) 2004-08-30
CZ299947B6 (cs) 2009-01-07
HRP20031067A2 (en) 2004-04-30
FR2826274B1 (fr) 2003-09-26
EP1401397A2 (fr) 2004-03-31
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
CN1529585A (zh) 2004-09-15
HRP20031067B1 (en) 2011-10-31
UY27341A1 (es) 2003-01-31
UA77960C2 (en) 2007-02-15
JO2325B1 (en) 2006-06-28
US20040142029A1 (en) 2004-07-22
MY134340A (en) 2007-12-31
US20070014857A1 (en) 2007-01-18
NZ530042A (en) 2005-09-30
ECSP034915A (es) 2004-02-26
WO2003000225A3 (fr) 2003-03-13
SK285865B6 (sk) 2007-10-04
MXPA03011756A (es) 2004-07-01
FR2826274A1 (fr) 2002-12-27
ATE290366T1 (de) 2005-03-15
CZ20033441A3 (en) 2004-03-17
TWI228049B (en) 2005-02-21
JP4880871B2 (ja) 2012-02-22
SV2003001098A (es) 2003-03-18
BG108458A (bg) 2005-02-28
US7138138B2 (en) 2006-11-21
JP2004534810A (ja) 2004-11-18
OA12635A (fr) 2006-06-15
BRPI0208998A2 (pt) 2017-06-06
MA27042A1 (fr) 2004-12-20
SK15922003A3 (sk) 2004-05-04
IL159404A0 (en) 2004-06-01
CA2452239C (fr) 2011-07-19
CO5540278A2 (es) 2005-07-29
CA2452239A1 (fr) 2003-01-03
AP1595A (en) 2006-04-12
NO332258B1 (no) 2012-08-13
PE20030201A1 (es) 2003-03-12
IL159404A (en) 2007-08-19
AU2002329311B2 (en) 2007-02-01
BG66314B1 (bg) 2013-04-30
HUP0400799A3 (en) 2012-08-28
EA006016B1 (ru) 2005-08-25
NO20035581D0 (no) 2003-12-15
HK1067558A1 (en) 2005-04-15
PT1401397E (pt) 2005-05-31

Similar Documents

Publication Publication Date Title
AR036096A1 (es) Formulacion farmaceutica de sabor enmascarado, un procedimiento para su preparacion y un procedimiento de enmascaramiento del sabor de productos farmaceuticos
JP5433415B2 (ja) 粘膜炎を治療および予防するための方法
ES2561108T3 (es) Composiciones inyectables para la liberación controlada de compuesto farmacológicamente activo
RU2645087C2 (ru) Фармацевтические составы для местного применения, содержащие низкую концентрацию бензоилпероксида в суспензии в воде и смешивающимся с водой органическом растворителе
UY26628A1 (es) Películas consumibles oralmente que se disuelven rapidamente que contienen una resina de intercambio de iones como agente que enmascara el sabor
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR057422A1 (es) Uan composicion farmaceutica de liberacion modificada, proceso de preparacion de dicha composicion y metodo para emplear la misma
US20070269537A1 (en) Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System
AR027179A1 (es) Formulas farmaceuticas liquidas de sabor enmascarado
CO6150127A2 (es) Formulaciones de flibanserina y metodo para fabricarlas
RU2003132426A (ru) Фармацевтический раствор арипипразола для орального применения
BRPI0403935B8 (pt) formas de dosagem de azitromicina com efeitos colaterais reduzidos
AR035533A1 (es) Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
WO2006007354A3 (en) A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
AR033688A1 (es) Composicion parenteral reconstituible
AR010716A1 (es) Formulacion para tabletas efervecentes desinfectantes y metodo para formar una solucion desinfectante
BR0115989A (pt) Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
AR006345A1 (es) Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion.
PE20030545A1 (es) Formulaciones de jarabe de ribavirina
ATE424191T1 (de) Ph-unabhängige pharmazeutische formulierungen mit verlängerter freisetzung
AR067630A1 (es) Soluciones farmaceuticas de telbivudina y metodo de tratamiento
WO2022010444A1 (en) Niclosamide for the treatment of viral diseases
AR030715A1 (es) Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones
US20130196934A1 (en) Composition for perinatal and neonatal stroke
AR044697A1 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato

Legal Events

Date Code Title Description
FC Refusal